Skip to main content
construction release_alert
Profile editing is temporarily unavailable from June 11-24, 2026 while manual profile data entry transitions to Elements. Learn More.
cancel
Journal cover image

Early initiation of prophylactic immune tolerance induction and enzyme replacement therapy in prenatally diagnosed infantile onset Pompe disease with a CRIM-negative mutation

Publication ,  Conference
Gupta, P; Shayota, B; Gomez, A; Tambini-King, L; Kazi, Z; Kishnani, PS
Published in: Molecular Genetics and Metabolism
January 2017

Duke Scholars

Published In

Molecular Genetics and Metabolism

DOI

ISSN

1096-7192

Publication Date

January 2017

Volume

120

Issue

1-2

Start / End Page

S60 / S60

Publisher

Elsevier BV

Related Subject Headings

  • Genetics & Heredity
  • 3202 Clinical sciences
  • 3105 Genetics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gupta, P., Shayota, B., Gomez, A., Tambini-King, L., Kazi, Z., & Kishnani, P. S. (2017). Early initiation of prophylactic immune tolerance induction and enzyme replacement therapy in prenatally diagnosed infantile onset Pompe disease with a CRIM-negative mutation. In Molecular Genetics and Metabolism (Vol. 120, pp. S60–S60). Elsevier BV. https://doi.org/10.1016/j.ymgme.2016.11.134
Gupta, Punita, Brian Shayota, Alejandra Gomez, Lorien Tambini-King, Zoheb Kazi, and Priya S. Kishnani. “Early initiation of prophylactic immune tolerance induction and enzyme replacement therapy in prenatally diagnosed infantile onset Pompe disease with a CRIM-negative mutation.” In Molecular Genetics and Metabolism, 120:S60–S60. Elsevier BV, 2017. https://doi.org/10.1016/j.ymgme.2016.11.134.
Gupta P, Shayota B, Gomez A, Tambini-King L, Kazi Z, Kishnani PS. Early initiation of prophylactic immune tolerance induction and enzyme replacement therapy in prenatally diagnosed infantile onset Pompe disease with a CRIM-negative mutation. In: Molecular Genetics and Metabolism. Elsevier BV; 2017. p. S60–S60.
Gupta, Punita, et al. “Early initiation of prophylactic immune tolerance induction and enzyme replacement therapy in prenatally diagnosed infantile onset Pompe disease with a CRIM-negative mutation.” Molecular Genetics and Metabolism, vol. 120, no. 1–2, Elsevier BV, 2017, pp. S60–S60. Crossref, doi:10.1016/j.ymgme.2016.11.134.
Gupta P, Shayota B, Gomez A, Tambini-King L, Kazi Z, Kishnani PS. Early initiation of prophylactic immune tolerance induction and enzyme replacement therapy in prenatally diagnosed infantile onset Pompe disease with a CRIM-negative mutation. Molecular Genetics and Metabolism. Elsevier BV; 2017. p. S60–S60.
Journal cover image

Published In

Molecular Genetics and Metabolism

DOI

ISSN

1096-7192

Publication Date

January 2017

Volume

120

Issue

1-2

Start / End Page

S60 / S60

Publisher

Elsevier BV

Related Subject Headings

  • Genetics & Heredity
  • 3202 Clinical sciences
  • 3105 Genetics